A transperineal prostate biopsy is a procedure where a needle is inserted through the perineum (the skin between the scrotum and the rectum) to collect tissue samples from the prostate. This approach avoids passing the needle through the rectal wall, which significantly lowers the risk of serious infection. It has become the preferred method at many urology centers because of its safety profile and its ability to reach parts of the prostate that the older transrectal approach often misses.
How the Procedure Works
During a transperineal biopsy, you lie on your back with your legs in stirrups. An ultrasound probe is placed in the rectum for imaging, but the biopsy needle itself enters through the perineal skin, not through the rectum. The urologist uses real-time ultrasound to guide the needle into specific areas of the prostate and collect small cores of tissue, typically 12 to 24 samples depending on the situation.
There are two main techniques. In the freehand approach, the urologist inserts a needle through one or two small puncture sites and angles it in a fan-like pattern to sample different zones. This requires fewer skin punctures and relies heavily on the clinician’s skill with ultrasound guidance. In the template-guided approach, a grid (similar to what’s used in radiation seed placement) is positioned against the perineum. The grid provides a precise coordinate system, allowing the needle to be guided into pre-planned locations. Both techniques produce comparable cancer detection rates, though the freehand method tends to cause less urinary retention afterward.
MRI-fusion technology can be layered onto either technique. If a suspicious area was spotted on a previous MRI, the urologist can overlay those images onto the live ultrasound feed and direct the needle to that specific target while still sampling the rest of the gland systematically.
Why It Detects More Cancers
The front (anterior) portion of the prostate is notoriously hard to reach with a transrectal biopsy, where the needle enters from behind. The transperineal route approaches the prostate from below, giving direct access to the anterior zone. This matters more than it might sound: in one large study, over half of all prostate cancers involved the anterior zone, and nearly 10% of cancers were found exclusively in the anterior region, with about half of those being clinically significant.
The difference is even more striking in men who previously had a negative transrectal biopsy but still have elevated PSA levels. In repeat biopsy studies, anterior cancers accounted for 44% to as high as 94% of positive findings, depending on the study population. A head-to-head comparison of MRI-targeted biopsies found that the transperineal approach detected clinically significant cancer in the anterior zone 93% of the time, compared to just 25% for the transrectal approach targeting the same lesions.
Lower Infection Risk
The most important safety advantage is the dramatically lower rate of sepsis. Transrectal biopsies push a needle through the rectal wall, introducing bacteria from the gut into the prostate and bloodstream. Published sepsis rates for transrectal biopsies range from 0.4% to 9.8%. For the transperineal approach, sepsis rates range from 0% to 1%. The perineal skin is far cleaner than the rectal lining, and this difference in contamination risk is the core reason many guidelines now favor the transperineal route.
Antibiotic use before the procedure is still standard, but some centers performing transperineal biopsies have explored reduced antibiotic protocols since the infection risk is inherently lower.
Anesthesia and What You’ll Feel
Transperineal biopsies were traditionally done under general anesthesia, but local anesthesia in an office setting has become increasingly common. The local approach involves several steps because the needle passes through skin, fat, and muscle before reaching the prostate.
First, the urologist numbs the perineal skin on both sides with a local anesthetic, creating a zone of numbness across the entire area between the inner thighs. Then a deeper injection numbs the tissue along the needle’s path. Finally, anesthetic is deposited near the prostate itself, particularly around the apex where the gland sits closest to the perineum. For larger prostates or when many cores are planned, additional numbing around the base of the gland is recommended. The whole process uses roughly 20 milliliters of local anesthetic.
Most patients tolerate the procedure well under local anesthesia alone, though some experience discomfort that requires additional injections or a switch to sedation. The procedure itself typically takes 15 to 30 minutes.
Preparing for the Biopsy
Preparation is straightforward. You’ll likely be asked to provide a urine sample beforehand to rule out a urinary tract infection, since an active infection means the biopsy needs to be postponed. Blood-thinning medications like warfarin, aspirin, and ibuprofen are usually stopped several days before the procedure. Your urologist may ask you to do a cleansing enema at home before your appointment, since the ultrasound probe still needs to be inserted rectally for imaging. You’ll also take a course of antibiotics starting before the biopsy.
Recovery and Side Effects
Because the needle enters through the skin rather than the rectal wall, rectal bleeding is not a concern the way it can be with transrectal biopsies. You can expect some blood in your urine for a few days, and blood in your semen for several weeks. Mild soreness or bruising at the perineum is common and usually resolves within a few days.
The main side effect specific to the transperineal approach is a slightly higher chance of temporary difficulty urinating, especially with template-guided biopsies that involve multiple skin punctures. This swelling-related retention typically resolves on its own or with a short-term catheter. Freehand techniques, which use fewer puncture sites, appear to carry a lower risk of this complication.
Most men return to normal activities within a day or two. Strenuous exercise is generally avoided for about a week. Biopsy results typically come back within one to two weeks, at which point your urologist will discuss next steps based on what the tissue samples show.